following a facility inspection which found violations of good manufacturing practices which cause the company's products to be adulterated
Use of CRISPR/Cas9-engineered INS-1 pancreatic cells to define the pharmacology of dual GIPR/GLP-1R agonists
OPSS.org - BPC-157: A prohibited peptide and an unapproved drug: Details regulatory status, WADA ban, and unapproved drug classification
Zhao X, Gan L, Pan H, Kan D, Majeski M, Adam SA, Unterman TG (2004) Multiple elements regulate nuclear/cytoplasmic shuttling of FOXO1: characterization of phosphorylation- and 14-3-3-dependent and -independent mechanisms
Weight loss outcomes depend primarily on consistent GLP-1 dosing, caloric deficit, and lifestyle factors